MIT Sloan HSI researchers are at the forefront of addressing many facets of the COVID-19 Pandemic, bringing their specific expertise to bear on the many healthcare challenges.
The resurgence of tuberculosis is behavioral, not medical. Nudges can fix it – Researchers: Erez Yoeli, David Rand, and Jon Rathauser
HSI’s researchers are leading many groundbreaking projects that address a specific condition or disease.
Through a landmark operations research study in Mozambique, Jónas Jónasson and his colleagues have recently investigated ways to speed up not only lab procedures, but also the supply chain itself.
Armed with advanced AI, machine learning, and sophisticated models, Dimitris Bertsimas and colleagues are designing safe and effective chemotherapy regimens, starting with gastric cancer.
Kate Kellogg shows that implementing new processes and workflows requires finding those with leverage and giving them tools and tactics to change daily interactions and institutionalize the changes.
HSI's leadership team includes our Advisory Board as well as Faculty and Staff.
Steve Rusckowski, SM ’84, former chairperson, CEO, and president of Quest Diagnostics, believes small changes can have a major impact on company culture.
Andrea Ippolito, SDM ’12, and Mark Rangell, SM ’89, met through the MIT network and partnered to provide breast and baby feeding support to babies and their parents.
Financial experts call for more aid to small businesses, more liquidity for banks, penalty-free access to retirement accounts — and a safe return to work.
